Regencell Bioscience Holdings Ltd
RGC
View Detailed Chart
16.810USD
-1.630-8.84%
Close 10/10, 16:00（ET）Quotes delayed by 15 min
8.31BMarket Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-8.84%
5 Days
+4.09%
1 Month
+23.88%
6 Months
-43.40%
Year to Date
+240.28%
1 Year
+219.47%
View Detailed Chart
TradingKey Stock Score of Regencell Bioscience Holdings Ltd
Currency: USD Updated: 2025-10-09Key Insights
Its valuation is considered undervalued,and institutional recognition is low. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Regencell Bioscience Holdings Ltd's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Regencell Bioscience Holdings Ltd Highlights
StrengthsRisks
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Undervalued
The company’s latest PE is -105.06, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 680.91K shares, increasing 32.86% quarter-over-quarter.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Regencell Bioscience Holdings Ltd Info
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Ticker SymbolRGC
CompanyRegencell Bioscience Holdings Ltd
CEO
Websitehttps://www.regencellbioscience.com/
Related Instruments
-15.69%
-0.99%
-1.26%
-2.34%
-4.68%
-2.32%
-2.91%
-5.74%
-2.25%
-3.37%
-2.43%
-0.43%
-1.88%
-1.09%
-0.17%
-5.98%
+0.30%
-2.07%
+1.31%
0.00%Popular Symbols
